Skip to main content
. 2023 Mar 8;14:1134877. doi: 10.3389/fendo.2023.1134877

Table 3.

Changes in blood glucose indicators in the two groups, (mean ± SD) or M (P25, P75).

Indicators Group Time points Z/P b Ft/Pt Fg/Pg Fi/Pi
Pre Week 6 Week 12
FPG CG 7.55 ± 2.09 7.74 ± 1.85 7.70 ± 1.75 0.471/0.598 1.004/0.322 2.338/0.103 0.30 (-0.40,1.03)
IG 8.32 ± 2.67 7.99 ± 2.39 7.60 ± 1.95 -0.40 (-1.65, -0.80)
Z -2.133
Pa 0.033
GSP CG 3.22 ± 0.35 2.94 ± 0.29† 2.81 ± 0.28†† 86.420/<0.01 2.191/0.147 4.672/0.016 -0.35 (-0.67, -0.18)
IG 3.43 ± 0.56 3.03 ± 0.38† 2.83 ± 0.37†† -0.47 (-0.92, -0.25)
F 4.220 1.662 0.056 -1.840
P 0.047 0.210 0.815 0.066
HbA1c CG 7.0 (6.4, 7.7) / 6.9 (6.2, 7.8) -1.031/0.303 -0.2 (-0.2, 0.3)
IG 7.0 (6.4, 8.6) / 6.9 (6.5, 8.7) -0.598/0.550 0.0 (-0.4, 0.3)
Z -0.515 -0.647 -0.394
P a 0.606 0.517 0.694
a

Mann–Whitney U test;

b

Wilcoxon signed rank test; Ft/Pt, Fg/Pg , and Fi/Pi : two-way repeated measures ANOVA, time effect, group effect and group. *time interaction;

†: P<0.05 vs. Pre; ††: P<0.05 vs. Week 6; CG, control group; IG, intervention group; SD, standard deviation; △, value at week 12 minus value at pre.